Cvetkovic, D., Connolly D.C., Hamilton, T.C. Molecular biology and molecular genetics of ovarian, primary peritoneal, and fallopian tube cancer. In Gynecologic Cancer: Controversies in Management, edited by Gershenson, Gore, McGuire, Quinn, and Thomas. Elsevier Science, Philadelphia, PA, Section 3, Chapter 28, pp. 385-398, 2004.
Danielson, A.J., Christensen, T.A., Lovejoy, C.A., Adelsman, M.A., Connolly, D.C., Maihle, N.J. Membrane localization of v-ErbB is required but not sufficient for ligand-independent transformation. Exp. Cell Res. 296:285-293, 2004.
Nikitin, A.Y., Connolly, D.C., Hamilton, T.C. Pathology of ovarian neoplasms in genetically modified mice. Comp. Med. 54:26-28, 2004.
Ozols, R.F., Bookman, M.A., Connolly, D.C., Daly, M.B., Godwin, A.K., Schilder, R.J., Xu, X., Hamilton, T.C. Focus on epithelial ovarian cancer. Cancer Cell 5:19-24, 2004.
Connolly, D.C., Bao, R., Nikitin, A.Y., Stephens, K.C., Poole, T., Hua, X., Harris, S.S., Vanderhyden, B.C., Hamilton, T.C. Female mice chimeric for the expression of the SV40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res. 63:1389-1397, 2003.
Hamilton, T.C., Connolly, D.C., Nikitin, A.Y., Garson, K., Vanderhyden, B.C. Translational research in ovarian cancer: A must. Int. J. of Gynecol. Cancer 13:1-11, 2003.
Hamilton, T.C., Connolly, D.C., Daly, M.B. and Ozols, R.F. Ovarian Cancer Prevention. 39th ASCO Annual Meeting, (Educational Book), 283-290, 2003.